|
Diabetes, Vol 44, Issue 9 1132-1138, Copyright © 1995 by American Diabetes Association
Treatment of autoimmune diabetes and insulitis in NOD mice with heat shock protein 60 peptide p277
D Elias and IR Cohen
Department of Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
We recently showed that a peptide of the M(r) 60,000 heat shock protein
molecule, designated peptide p277, is a target of T-cells in autoimmune
diabetes in NOD mice. Indeed, the p277 peptide could be used as a
therapeutic agent to arrest the autoimmune process even after it was far
advanced. The present study was done to document the effects of p277
therapy on inflammation of the islets and on T-cell responsiveness to p277.
Groups of female NOD mice of various ages up to 17 weeks were treated with
a single inoculation of p277 given before or after the onset of overt
hyperglycemia. We now report that fragments of p277 can affect diabetes but
that optimal therapy requires the whole peptide. The positive response to
p277 was dependent on administration of a threshold dose of peptide.
Therapy was accompanied by the regression of intra-islet inflammation and
the reappearance of histologically normal islets. Successful peptide
therapy was associated with downregulation of T-cell immunity to p277.
Adoptive transfer experiments demonstrated that the spleen cells of
p277-treated mice were no longer diabetogenic and also could suppress the
diabetogenic potential of cotransferred spleen cells of untreated female
NOD mice. These results indicate that specific treatment of diabetes with a
defined peptide can reprogram the autoimmune response.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Nussbaum, A. Zanin-Zhorov, F. Quintana, O. Lider, and I. R. Cohen
Peptide p277 of HSP60 signals T cells: inhibition of inflammatory chemotaxis
Int. Immunol.,
October 1, 2006;
18(10):
1413 - 1419.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Quinn, M. McInerney, D. Huffman, B. McInerney, S. Mayo, K. Haskins, and E. Sercarz
T cells to a dominant epitope of GAD65 express a public CDR3 motif
Int. Immunol.,
June 1, 2006;
18(6):
967 - 979.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Lillicrap, R. C. Duggleby, J. C. Goodall, and J. S. H. Gaston
T cell recognition of a highly conserved epitope in heat shock protein 60: self-tolerance maintained by TCR distinguishing between asparagine and aspartic acid
Int. Immunol.,
March 1, 2004;
16(3):
405 - 414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Uray, F. Hudecz, G. Fust, and Z. Prohaszka
Comparative analysis of linear antibody epitopes on human and mycobacterial60-kDa heat shock proteins using samples of healthy blood donors
Int. Immunol.,
October 1, 2003;
15(10):
1229 - 1236.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Yoshida, T. Martin, K. Yamamoto, C. Dobbs, C. Munz, N. Kamikawaji, N. Nakano, H.-G. Rammensee, T. Sasazuki, K. Haskins, et al.
Evidence for shared recognition of a peptide ligand by a diverse panel of non-obese diabetic mice-derived, islet-specific, diabetogenic T cell clones
Int. Immunol.,
December 1, 2002;
14(12):
1439 - 1447.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Karges, K. Pechhold, S. Al Dahouk, I. Riegger, M. Rief, A. Wissmann, R. Schirmbeck, C. Barth, and B. O. Boehm
Induction of Autoimmune Diabetes Through Insulin (but Not GAD65) DNA Vaccination in Nonobese Diabetic and in RIP-B7.1 Mice
Diabetes,
November 1, 2002;
51(11):
3237 - 3244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Wilson, T. C. White, and D. DeLuca
Therapeutic Alteration of Insulin-Dependent Diabetes Mellitus Progression by T Cell Tolerance to Glutamic Acid Decarboxylase 65 Peptides In Vitro and In Vivo
J. Immunol.,
July 1, 2001;
167(1):
569 - 577.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Quintana, A. Rotem, P. Carmi, and I. R. Cohen
Vaccination with Empty Plasmid DNA or CpG Oligonucleotide Inhibits Diabetes in Nonobese Diabetic Mice: Modulation of Spontaneous 60-kDa Heat Shock Protein Autoimmunity
J. Immunol.,
December 1, 2000;
165(11):
6148 - 6155.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Becker, R. E. LaPorte, I. Libman, M. Pietropaolo, and H.-M. Dosch
Prevention of Type 1 Diabetes: Is Now the Time?
J. Clin. Endocrinol. Metab.,
February 1, 2000;
85(2):
498 - 506.
[Full Text]
|
 |
|

|
 |

|
 |
 
F. Lepault and M. C. Gagnerault
Characterization of Peripheral Regulatory CD4+ T Cells That Prevent Diabetes Onset in Nonobese Diabetic Mice
J. Immunol.,
January 1, 2000;
164(1):
240 - 247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Elias, Y. Tikochinski, G. Frankel, and I. R. Cohen
Regulation of NOD mouse autoimmune diabetes by T cells that recognize a TCR CDR3 peptide
Int. Immunol.,
June 1, 1999;
11(6):
957 - 966.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. S. Birk, S. L. Gur, D. Elias, R. Margalit, F. Mor, P. Carmi, J. Bockova, D. M. Altmann, and I. R. Cohen
The 60-kDa heat shock protein modulates allograft rejection
PNAS,
April 27, 1999;
96(9):
5159 - 5163.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 by the American Diabetes Association.
|
|
| |
|